2.94

0.34% -0.01

Eupraxia Pharmaceuticals Inc (EPRX)

Overview News Price History Discussions Forecast

Eupraxia Pharmaceuticals Inc stock is currently priced at $2.94, with a 24-hour trading volume of 4,760. It has seen a -0.34% decreased in the last 24 hours and a +10.32% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $2.96 pivot point. If it approaches the $2.94 support level, significant changes may occur.

Previous Close:

$2.95

Open:

$2.9

24h Volume:

4,760

Market Cap:

$104.73M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+1.38%

1M Performance:

+10.32%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$2.90

$2.95

52W Range:

$2.48

$3.08

Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile

Name

Eupraxia Pharmaceuticals Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

Address

Employee

Twitter

Next Earnings Date

2024-06-06

Latest SEC Filings

EPRX's Discussions on Twitter

Eupraxia Pharmaceuticals Inc Stock (EPRX) Latest News

Closing Bell: Eupraxia Pharmaceuticals Inc WT flat on Monday (EPRX-WT) - The Globe and Mail

The Globe and Mail

Closing Bell: Eupraxia Pharmaceuticals Inc up on Friday (EPRX) - The Globe and Mail

The Globe and Mail

Eupraxia Pharmaceuticals Sets Virtual Shareholder Meeting - TipRanks.com - TipRanks

TipRanks

Eupraxia Pharmaceuticals Inc Stock (EPRX) Financials Data

There is no financial data for Eupraxia Pharmaceuticals Inc (EPRX). Check out other stocks for more information.

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms.